(Q36315466)

13 August 2017

General population norms for the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI) (English)

1 reference

13 August 2017

John Peipert

2

0 references

Zeeshan Butt

object named as

Zeeshan Butt

series ordinal

1

0 references

David Cella

series ordinal

5

object named as

David Cella

1 reference

13 August 2017

Kimberly Webster

3

1 reference

PMCID

3470751

13 August 2017

Connie Chen

series ordinal

4

1 reference

PMCID

3470751

13 August 2017

language of work or name

English

0 references

publication date

6 July 2012

1 reference

13 August 2017

1 reference

13 August 2017

119

1 reference

13 August 2017

2

1 reference

13 August 2017

429-437

1 reference

Patient-reported outcomes in a phase iii study of everolimus versus placebo in patients with metastatic carcinoma of the kidney that has progressed on vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470751

Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470751

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470751

Half standard deviation estimate of the minimally important difference in HRQOL scores?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470751

A Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470751

Development and validation of a scale to measure disease-related symptoms of kidney cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470751

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470751

Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470751

What Are the Most Important Symptom Targets When Treating Advanced Cancer? A Survey of Providers in the National Comprehensive Cancer Network (NCCN)

30 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.27688

Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470751

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470751

22 September 2018

Identifiers

DOI

10.1002/CNCR.27688

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

PMCID

3470751